Description
An RBP4 antagonist (Ki = 8.3 nM for disruption of RBP4 binding to transthyretin); selective for RBP4 over CRBP1 (IC50s = 0.09 and >30 µM, respectively, in radioligand binding assays), as well as a panel of G protein-coupled receptors, kinases, and enzymes; reduces serum levels of RBP4 and retinol levels in mice at 30 mg/kg; inhibits retinal bisretinoid accumulation in the Abca4-/- mouse model of enhanced retinal lipofuscinogenesis-induced macular degeneration
Formal name: 2-[[[4-[2-(trifluoromethyl)phenyl]-1-piperidinyl]carbonyl]amino]-benzoic acid
Synonyms:
Molecular weight: 392.4
CAS: 1152782-19-8
Purity: ≥95%
Formulation: A crystalline solid